Lung Cancer Prognosis Market - Latest Trends, Capability Assessment up to 2025

Stratview Research announces the launch of a new research report on the Lung Cancer Prognosis Market. This extensive report from Stratview Research, studies the global lung cancer prognosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Click here to read the detailed description:
https://www.stratviewresearch.com/425/lung-cancer-prognosis-market.html

This Interventional Radiology Market analysis has been segmented in five ways, keeping in mind the interest of all the stakeholders across the value chain.
• By Treatment Algorithm – APAC, North America, Western Europe, Rest of The World
• By Procedures - Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive
• By Device - Surgical (Clamps, Forceps, Retractors, Others), Monitoring Devices (Camera, Trocar and Endoscopic Instrument)
• By End-User - Public Hospitals, Private Hospitals
• By Region - North America, Western Europe, Asia-Pacific, Latin America, Rest of the World

Click here to request the detailed TOC of the report:-
https://www.stratviewresearch.com/toc/425/lung-cancer-prognosis-market.html
OR
Request a sample here:-
https://www.stratviewresearch.com/Request-Sample/425/lung-cancer-prognosis-market.html

The Lung Cancer Prognosis Market: Highlights

Oncologists are increasingly prescribing targeted drugs for tumour with specific molecular aberrations such as inhibitors of changed or amplified proteins such as EGFR or ALK in lung cancer. Among other trends, increased use of antibody (replacing) than chemotherapy, is revolutionizing the treatment of lung cancer. These paradigm shifts in treatment is changing the overall way Lung cancer is treated in the developed markets.

The study identifies the shift behind shift of lung cancer surgery in elderly patients and female patients, and a decrease in the proportion of patients requiring extensive pulmonary resection. Stages of lung cancer can help a doctor identify the best course of treatment, hence it is important to study the market from diagnostics and surgical procedures used to treat this condition. There are several tests to detect the stage and spread of the condition including biopsy, Imaging scans (PET, CT), Lung Function Test (Spirometry). The study gives insight on the population that requires surgery and looks at the population which are treated with medicines, depending on the metastasis.

Tyrosine-kinase inhibitors (TKIs) are gradually becoming the most popular option for lung cancer treatment in China. While in the developed markets such as the USA, cancer is no longer a single tumour type diagnosis but is defined by a combination of factors, including histology and biomarker status. The variation in treatment and requirement of surgery or just medication impacts all the stakeholders in the market who are attached as diagnostic equipment, surgical equipment, pharmaceutical or any support services, across the globe.

Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook

The Burning Questions This Report Will Answer:
1. Over 1.5 million people worldwide die from lung cancer per year; why does the disease still has an extremely poor prognosis with all the modern technology?
2. What are the options available for accurate prediction of lung cancer?
3. Which market is more lucrative pharma, diagnostics or surgery?
4. Which technologies are available currently and how will the future technologies disrupt the market?

Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html

About Stratview Research
Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

This release was published on openPR.